Merck & Co., headquartered in Rahway, New Jersey, employs 72,000 people and provides health solutions through pharmaceuticals, vaccines, and animal health products. Its lead candidate is MK-6070, targeting DLL3.
MRK has been in the news recently: Merck & Co. Inc. will acquire Verona Pharma plc for approximately $10 billion, with a price of $107 per American Depositary Share (ADS). Additionally, insights from Dr. James R. Berenson on multiple myeloma highlight that many patients can live over 10 years after diagnosis.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
